Gemini amphiphiles: A novel class of nonviral gene delivery vectors

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 27, Issue 3, 2010, Pages 237-278

  Kumar, Mukesh ^a   Jinturkar, Kaustubh ^a   Yadav, M R ^a   Misra, Ambikanandan ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

gemini lipid; gemini surfactant; gene delivery; nonviral vectors; transfection

Indexed keywords

AMPHOPHILE; CARDIOLIPIN; CHOLESTEROL; DETERGENT; GEMINI LIPID; GEMINI SURFACTANT; LIPOSOME; NAKED DNA; PLASMID DNA; QUATERNARY AMMONIUM DERIVATIVE; SURFACTANT; UNCLASSIFIED DRUG;

CARCINOGENICITY; DNA TRANSFECTION; ELECTROPORATION; GENE GUN; IMMUNOGENICITY; INTRACELLULAR TRANSPORT; MACROMOLECULE; NONVIRAL GENE DELIVERY SYSTEM; PH; PHYSICAL CHEMISTRY; POLYMERIZATION; REVIEW; STRUCTURE ACTIVITY RELATION; TRANSGENE; ANIMAL; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; GENE TRANSFER; GENE VECTOR; HUMAN; PATENT; TRENDS;

ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MODELS, GENETIC; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PATENTS AS TOPIC; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE-ACTIVE AGENTS;

EID: 77954320451     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.v27.i3.20     Document Type: Review

References (114)

1. Ledley FD. Pharmaceutical approach to somatic gene therapy. Pharm Res. 1996;13;1595-1614
2. Vacik J, Dean BS, Zimmer WE, Dean DA. Cell-specific nuclear import of plasmid DNA. Gene Ther. 1999;6:1006-1014
3. Schaffer DV, Lauffenburger DA. Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery. J Biol Chem. 1998;273:28004-28009
4. Cotton M, Wagner E. Non-viral approaches to gene therapy. Curr Opin Bio- technol. 1993;4:705-710
5. Gao X, Kim SK, Liu D. Nonviral gene delivery: What we know and what is next. The AAPS J. 2007;9:E92-104.
6. Potter H. Electroporation in biology: methods, applications, and instrumentation. Anal Biochem. 1988;174:361-373
7. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM, Delaere P, Branellec D, Schwartz B, Scherman D. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci US A. 1999;96:4262-4267
8. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A. 1993;90:11478-11482
9. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science. 1990;247: 1465-1468
10. The Journal of Gene Medicine Gene Therapy Clinical Trials Worldwide [Cited 2009 Dec 15]. Available from: http://www.wiley.co.uk/genmed/clinical.
11. Han S, Mahato RI, Sung YK, Kim SW. Development of biomaterials for gene therapy. Mol Ther. 2000;2:302-317
12. Tomlinson E, Rolland AP. Controllable gene therapy pharmaceutics of non- viral gene delivery systems. J Control Release. 1996;39:357-372
13. Danialou G, Comtois AS, Matecki S, Nalbantoglu J, Karpati G, Gilbert R, Geof- froy P, Gilligan S, Tanguay JF, Petrof B. Optimization of regional intraarterial naked DNA-mediated transgene delivery to skeletal muscles in a large animal model. Mol Ther. 2005;11:257-266
14. Yazawa H, Murakami T, Li HM, Back T, Kurosaka K, Suzuki Y, Shorts L, Akiyama Y, Maruyama K, Parsoneault E, Wiltrout RH, Watanabe M. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors. Cancer Gene Ther. 2006;13:993-1001.
15. Hickman MA, Malone RW, Lehmann BK, Sih TR, Knoell D, Szoka FC, Walzem R, Carlson DM, Powell JS. Gene expression following direct injection of DNA into liver. Hum Gene Ther. 1994;5:1477-1483
16. Budker V, Zhang G, Knechtle S, Wolff JA. Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Ther. 1996;3:593-598
17. Sawamura D, Abe R, Goto M, Akiyama M, Hemmi H, Akira S, Shimizu H. Direct injection of plasmid DNA into the skin induces dermatitis by activation of monocytes through toll-like receptor 9. J Gene Med. 2005;7:664-671
18. Choate KA, Khavari PA. Direct cutaneous gene delivery in a human genetic skin disease. Hum Gene Ther. 1997;8:1659-1665
19. Meyer KB, Thompson MM, Levy MY, Barron LG, Szoka FC. Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics. Gene Ther. 1995;2:450-460
20. Poutona CW, Seymour LW. Key issues in non-viral gene delivery. Adv Drug Del Rev. 2001;46: 187-203; 42-44
21. Wiethoff CM, Middaugh CR. Barriers to nonviral gene delivery. J Pharm Sci. 2003;92:203-217
22. Bally MB, Harvie P, Wong FMP, Kong S, Wasan EK, Reimer DL. Biological barriers to cellular delivery of lipid-based DNA carriers. Adv Drug Delivery Rev. 1999;38:291-315.
23. Kamiya H, Tsuchiya H, Yamazaki J, Harashima H. Intracellular trafficking and transgene expression of viral and non-viral gene vectors. Adv Drug Delivery Rev. 2001;52:153-164
24. Verma IM, Somia N. Gene therapy-promises, problems and prospects. Nature. 1997;389:239-242
25. Ledley FD. Non-viral gene therapy. Curr Opin Biotechnol. 1994;5:626-636
26. Anderson WF. Human gene therapy. Science. 1992;256:808-813
27. Anderson WF. Human gene therapy. Nature. 1998;392:25-30.
28. Young LS, Searle PF, Onion D, Mautner V. Viral gene therapy strategies: from basic science to clinical application. J Pathol. 2006;208:299-318.
29. Davis ME. Non-viral gene delivery systems. Curr Opin Biotechnol. 2002;13: 128-131
30. Hui S, Langner M, Zhao Y, Ross P, Hurley E, Chan K. The role of helper lipids in cationic liposome-mediated gene transfer. Biophys J. 1996;71:590-599
31. Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. BBA. 1995;1235:289-295
32. Boussif O, Lezoualch F, Zanta M, Mergny M, Scherman D, Demeneix B, Behr J. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci U S A. 1995;92: 7297-7301
33. Godbey W, Barry M, Saggau P, Wu K, Mikos A. Poly(ethylenimine)-medi- ated transfection: A new paradigm for gene delivery. J Biomed Mater Res. 2000;51:321-328
34. Ciftci K, Levy R. Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts. Int J Pharm. 2001;218:81-92.
35. Plank C, Oberhauser B, Mechtler K, Koch C, Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer system. J Biol Chem. 1994;269:12918-12924
36. Capecchi M. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell. 1980;22:479-488
37. Menger FM, Littau CA. Gemini surfactants: A new class of self-assembling molecules. J Am Chem Soc. 1993;115:10083-10090
38. Layn KM, Debenedetti PG, Prudhomme RK. A theoretical study of gemini surfactant phase behavior. J Chem Phys. 1998;109:5651-5658
39. Menger FM, Keiper JS, Mbadugha BNA, Caran KL, Romsted LS. Gemini surfactants with acetylenic spacers. Langmuir. 2000;16:9095-9098
40. Renouf P, Mioskowski C, Lebeau L, Hebrault D, Desmurs JR. Dimeric surfactants: first synthesis of an asymmetrical gemini compound. Tetrahedron Lett. 1998;39:1357-1360
41. Oda R, Huc I, Candau SJ. Geminis surfactant, the effect of hydrophobic chain- length and dissymmetry. Chem Commun. 1997;2105-2106
42. Rosen MJ, Gao T, Nakatsuji Y, Masuyama A. Synergism in binary mixtures of surfactants 12. Mixtures containing surfactants with two hydrophilic and two or three hydrophobic groups. Colloids Surf A. 1994;88:1-11.
43. Zana R, Levy H, Papoutsi D, Beinert G. Micellization of two triquaternary ammonium surfactants in aqueous solution. Langmuir. 1995;11:3694-3698
44. Hait SK, Moulik SP. Gemini surfactants: A distinct class of self-assembling molecules. Curr Sci. 2002;82:1101-1111
45. Bombelli C, Giansanti L, Luciani P, Mancini G. Gemini surfactant based carriers in gene and drug delivery. Curr Med Chem. 2009;16:171-183
46. Pullmannova P, Uhrikova D, Funari SS, Lacko I, Devinsky F, Balgavy P. Polymorphic phase behavior of DNA-DOPE-Gemini surfactant aggregates: A small angle X-ray diffraction. Acta Facultatis Pharmaceuticae Universitis Comenianae. 2008;170-182
47. Felgner PL, Gadek TR, Holm M. Lipofection: a highly efficient lipid mediated DNA transfection procedure. Proc Natl Acad Sci U S A. 1987;84:7413-7417
48. Chicco AJ, Sparagna GC. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol. 2007;292:33-44.
49. Matsumoto K, Kusaka J, Nishibori A, Hara H. Lipid domains in bacterial membranes. Mol Microbiol. 2006;61:1110-1117
50. Kasireddy K, Ahmad MU, Ali SM, Ahmad I. Synthesis of novel cationic car- diolipin analogues for the optimal delivery of therapeutic agents. Tetrahedron Lett. 2004;45:2743-2746
51. Kasireddy K, All SM, Ahmad MU, Choudhury S, Chien PY, Sheikh S, Ahmad I. Synthesis of cationic cardiolipin analogues. Bioorg Chem. 2005;33:345-362
52. Chesnoy S, Huang L. Structure and function of lipid-DNA complexes for gene delivery. Annu Rev Biophys Biomol Struct. 2000;29:27-47.
53. Safinya CR, Ewert K, Ahmad A, Evans HM, Raviv U, Needleman JD, Lin AJ, Slack NL, George C, Samuel CE. Cationic liposome-DNA complexes: from liquid crystal science to gene delivery applications. Phil Trans R Soc A. 2006;364:2573-2596
54. Chien PY, Wang J, Carbonaro D, Lei S, Milerr B, Sheikh S, Ali SM, Ahmad MU, Ahmad I. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo. Cancer Gene Ther. 2005;12:321-328
55. Bajaj A, Paul B, Kondaiah P, Bhattacharya S. Structure-activity investigation on the gene transfection properties of cardiolipin mimicking gemini lipid analogues. Bioconjug Chem. 2008;19:1283-1300
56. Chabaud P, Camplo M, Payet D, Serin G, Moreau L, Barthelemy P, Grinstaff MW. Cationic nucleoside lipids for gene delivery. Bioconjug Chem. 2006;17:466-472
57. Li S, Tseng WC, Stolz DB, Wu SP, Watkins SC, Huang L. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther. 1999;6:585-594
58. Bajaj A, Paul B, Indi SS, Kondaiah P, Bhattacharya S. Effect of the hydrocarbon chain and polymethylene spacer lengths on gene transfection efficacies of gemini lipids based on aromatic backbone. Bioconjug Chem. 2007;18:2144-2158
59. Bajaj A, Kondaiah P, Bhattacharya S. Gene transfection efficacies of novel cationic gemini lipids possessing aromatic backbone and oxyethylene spacers. Biomacromolecules. 2008;9:991-999
60. Van der Woude I, Wagenaar A, Meekel AA, Ter Beest MB, Ruiters MH, Eng- berts JB, Hoekstra D. Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery. Proc Natl Acad Sci U S A. 1997;94:1160-1165
61. Meekel AAP, Wagenaar A, Smisterova J, Kroeze JE, Haadsma P, Bosgraaf B, Stuart MCA, Brisson A, Ruiters MHJ, Hoekstra D, Engberts JBFN. Synthesis of pyridinium amphiphiles used for transfection and some characteristics of amphiphile/DNA complex formation. Eur J Org Chem. 2000;4:665-673
62. Roosjen A, Smisterova J, Driessen C, Anders JT, Wagenaar A, Hoekstra D, Hulst R, Engberts JBFN. Synthesis and characteristics of biodegradable pyridinium amphiphiles used for in vitro DNA delivery. Eur J Org Chem. 2002;7:1271-1277
63. Ilies MA, Seitz WA, Caproiu MT, Wentz M, Garfield RE, Balaban AT. Pyridinium-based cationic lipids as gene transfer agents. Eur J Org Chem. 2003;14:2645-2655
64. Ilies MA, Seitz WA, Ghiviriga I, Johnson BH, Miller A, Thompson EB, Balaban AT. Pyridinium cationic lipids in gene delivery: a structure-activity correlation study. J Med Chem. 2004;47:3744-3754
65. Matsuo H, Chevallier J, Mayran N, Le Blanc I, Ferguson C, Faure J, Blanc NS, Matile S, Dubochet J, Sadoul R, Parton RG, Vilbois F, Gruenberg J. Role of LBPA and Alix in multivesicular liposome formation and endosome organization. Science. 2004;303:531-534
66. Ilies MA, Seitz WA, Johnson BH, Ezell EL, Miller AL, Thompson EB, Balaban AT. Lipophilic pyrylium salts in the synthesis of efficient pyridinium-based cationic lipids, gemini Surfactants, and lipophilic oligomers for gene delivery. J Med Chem. 2006;49:3872-3887
67. Rose JK, Buonocore L, Whitt MA. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques. 1991;10:520-525
68. Rosenzweig HS, Rakhmanova VA, MacDonald C. Diquaternary ammonium compounds as transfection agents. Bioconjug Chem. 2001;12:258-263
69. Badea I, Wettig S, Verrall, R, Foldvari M. Gene delivery using gemini nanoparti- cles in interferon-y-deficient mice. Eur J Pharm Biopharm. 2007;65:414-422
70. Badea I, Verrall R, Baca-Estrada M, Tikoo S, Rosenberg A, Kumar P, Foldvari M. In vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexes. J Gene Med. 2005;7:1200-1214
71. Luciani P, Bombelli C, Colone M, Giansanti L, Ryhanen SJ, Saily VMJ, Mancini G, Kinnunen PKJ. Influence of the spacer of cationic gemini amphiphiles on the hydration of lipoplexes. Biomacromolecules. 2007;8:1999-2003.
72. Bombelli C, Faggioli F, Luciani P, Mancini G, Sacco MG. Efficient transfection of DNA by liposomes formulated with cationic gemini amphiphiles. J Med Chem. 2005;48:5378-5382 (Pubitemid 41113923)
73. Bombelli C, Borocci S, Diociaiuti M, Faggioli F, Galantini L, Luciani P, Man- cini G, Sacco MG. Role of the spacer of cationic gemini amphiphiles in the condensation of DNA. Langmuir. 2005;21:10271-10274 (Pubitemid 41692089)
74. Bombelli C, Faggioli F, Luciani P, Mancini G, Sacco MG. PEGylated lipoplexes: preparation protocols affecting DNA condensation and cell transfection efficiency. J Med Chem. 2007;50:6274-6278
75. Ryhanen SJ, Saily MJ, Paukku T, Borocci S, Mancini G, Holopainen JM, Kinnunen PKJ. Surface charge density determines the efficiency of cationic gemini surfactant based lipofection. Biophys J. 2003;84:578-587
76. Fisicaro E, Compari C, Duce E, Donofrio G, Rozycka-Roszak B, Wozniak E. Biologically active bisquaternary ammonium chlorides: physico-chemical properties of long chain amphiphiles and their evaluation as non-viral vectors for gene delivery. Biochim Biophys Acta. 2005;1722:224-233
77. Vijayanathan V, Thomas T, Antony T. Formation of DNA nanoparticles in the presence of novel polyamine analogues: a laser light scattering and atomic force microscopic study. Nucleic Acids Res. 2004;32:127-134
78. Vijayanathan V, Thomas T, Shirahata A. DNA condensation by polyamines: A laser light scattering study of structural effects. Biochemistry. 2001;40: 13644-13651
79. Wettig SD, Badea I, Donkuru MD, Verrall RE, Foldvari M. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles. J Gene Med. 2007;9:649-658
80. Gao X, Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun. 1991;179:280-285
81. Bajaj A, Kondiah P, Bhattacharya S. Design, synthesis, and in vitro gene delivery efficacies of novel cholesterol-based gemini cationic lipids and their serum compatibility: a structure-activity investigation. J Med Chem. 2007;50:2432-2442
82. Ghosh YK, Visweswariah SS, Bhattacharya S. Nature of linkage between the cationic headgroup and cholesteryl skeleton controls gene transfection efficiency. FEBS Lett. 2000;473:341-344
83. Ghosh YK, Visweswariah SS, Bhattacharya S. Advantage of the ether linkage between the positive charge and the cholesteryl skeleton in cholesterol- based amphiphiles as vectors for gene delivery. Bioconjug Chem. 2002;13: 378-384
84. Bajaj A, Kondaiah P, Bhattacharya S. Synthesis and gene transfer activities of novel serum compatible cholesterol-based gemini lipids possessing oxyethylene- type spacers. Bioconjug Chem. 2007;18:1537-1546
85. Tang F, Hughes JA. Introduction of a disulfide bond into a cationic lipid enhances transgene expression of plasmid DNA. Biochem Biophys Res Com- mun. 1998;242:141-145
86. Tang F, Hughes JA. Use of dithiodiglycolic acid as a tether for cationic lipids decreases the cytotoxicity and increases transgene expression of plasmid DNA in vitro. Bioconjugate Chem. 1999;10:791-796
87. Bajaj A, Kondiah P, Bhattacharya S. Effect of the nature of the spacer on gene transfer efficacies of novel thiocholesterol derived gemini lipids in different cell lines: A structure-activity investigation. J Med Chem. 2008;51:2533-2540
88. McGregor C, Perrin C, Monck M, Camilleri P, Kirby AJ. Rational approaches to the design of cationic gemini surfactants for gene delivery. J Am Chem Soc. 2001;123:6215-6220 (Pubitemid 32904647)
89. Camilleri P, Kremer A, Edwards A, Jennings K, Jenkins O, Marshall I, McGregor C, Neville W, Rice S, Smith R, Wilkinson M, Kirby A. A novel class of cationic gemini surfactants with efficient in vitro gene transfection properties. J Chem Soc Chem Commun. 2000;14:1253-1254
90. Jennings KH, Marshall ICB, Wilkinson MJ, Kremer A, Kirby AJ, Camilleri P. Aggregation properties of a novel class of cationic gemini surfactants correlate with their efficiency as gene transfection agents. Langmuir. 2002;18:2426-2429
91. Blessing T, Remy JS, Behr JP. Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci U S A. 1998;95:1427-1431
92. Behr JP. Photohydrolysis of DNA by polyaminobenzene diazonium salts. J Chem Soc, Chem Commun. 1989;(2):101-103
93. Dauty E, Remy JS, Blessing T, Behr JP. Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture. J Am Chem Soc. 2001;123:9227-9234
94. Ronsin G, Perrin C, Guedat P, Kremer A, Camilleri P, Kirby AJ. Novel spermine-based cationic gemini surfactants for gene delivery. J Chem Soc, Chem Commun. 2001;(21):2234-2235 (Pubitemid 33052119)
95. Buijnsters PA, Rodriguez CLG, Willighagen EL, Sommerdijk NAM, Kremer A, Camilleri P, Feiters MC, Nolte RJM, Zwanenburg B. Cationic gemini surfactants based on tartaric acid: Synthesis, aggregation, monolayer behaviour, and interaction with DNA. Eur J Org Chem. 2002;8:1397-1406
96. Bergsma M, Fielden ML, Engberts JBFN. pH-Dependent aggregation behavior of a sugar-amine gemini surfactant in water: vesicles, micelles, and monolay- ers of hexane-1,6-bis(hexadecyl-1′-deoxyglucitylamine). J Colloid Interface Sci. 2001;243:491-495
97. Johnsson M, Wagenaar A, Engberts JBFN. Sugar-based gemini surfactant with a vesicle-to-micelle transition at acidic pH and a reversible vesicle flocculation near neutral pH. J Am Chem Soc. 2003;125:757-760
98. Bell PC, Bergsma M, Dolbnya IP, Bras W, Stuart MCA, Rowan AE, Feiters MC, Engberts JBFN. Transfection mediated by gemini surfactants: Engineered escape from the endosomal compartment. J Am Chem Soc. 2003;125:1551-1558
99. Johnsson M, Wagenaar A, Stuart MCA, Engberts JBFN. Sugar-based gemini surfactants with pH-dependent aggregation behavior: vesicle-to-micelle transition, critical micelle concentration, and vesicle surface charge reversal. Langmuir. 2003;19:4609-4618
100. Klijn JE, Stuart MCA, Scarzello M, Wagenaar A, Engberts JBFN. pH-Depen- dent phase behavior of carbohydrate-based gemini surfactants. The effects of carbohydrate stereochemistry, head group hydrophilicity, and nature of the spacer. J Phys Chem B. 2007;111:5204-5211
101. Scarzello M, Klijn JE, Wagenaar A, Stuart MCA, Hulst R, Engberts JBFN. pH-dependent aggregation properties of mixtures of sugar-based gemini surfactants with phospholipids and single-tailed surfactants. Langmuir. 2006;22:2558-2568
102. Wasungu L, Scarzello M, Dam GV, Molema G, Wagenaar A, Engberts JBFN, Hoekstra D. Transfection mediated by pH sensitive sugar-based gemini surfactants; potential for in vivo gene therapy applications, J Mol Med. 2006;84:774-784
103. Wasungu L, Stuart MC, Scarzello M, Engberts JB, Hoekstra D. Lipoplexes formed from sugar-based gemini surfactants undergo a lamellar-to-micellar phase transition at acidic pH. Evidence for a non-inverted membrane-destabilizing hexagonal phase of lipoplexes. Biochim Biophys Acta. 2006;1758: 1677-1684
104. Asokan A, Cho MJ. Cytosolic delivery of macromolecules: synthesis and characterization of acid sensitive bis detergents. Bioconjugate Chem. 2004;15:1166-1173
105. Wang XL, Ramusovic S, Nguyen T, Lu ZR. Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery. Bioconjugate Chem. 2007;18:2169-2177
106. Camilleri P, Kirby AJ, Perrin C, McGregor C, inventors. Novel compounds. United States Patent Application US 20030119188A1. 2003 Jun 26.
107. Camilleri P, Kirby AJ, Perrin C, Rosin GAB, Guedat P, inventors. Novel compounds. United States Patent Application US 20040138139A1. 2004 Jul 15.
108. Camilleri P, Guedat P, Kirby AJ, Kremer A, inventors; SmithKlineBeecham plc, Cambridge University Technical Service Ltd. Novel compounds. United States Patent Application US 20050089493A1. 2005 Apr 28.
109. Castro MJ, Christopher K, Ladlow M, Patel A, inventors; Glaxo Group Limited, assignee. Ester-linked gemini surfactant compounds for use in gene therapy. United States Patent US 7425645 B2. 2008 Sept 16.
110. Castro MJ, Kitson C, Ladlow M, Patel A, inventors; Glaxo Group Limited, assignee. Compounds. United States Patent US 7569720 B2. 2009 Aug 4.
111. Wettig S, Verrall RE, Foldvari M. Inventors; University of Saskatchewan, assignee. Substituted diquaternary gemini compounds. United States Patent Application US 20090054368A1. 2009 Feb 26.
112. Castro MJ, Kitson C, Ladlow M, Patel A. inventors. Amide and peptide derivatives of tetraalkylenepentamines as transfection agents. United States Patent Application US 20090149401A1. 2009 Jun 11.
113. Wheeler C, inventor; Vical Inc, San Diego, assignee. Cytofectin dimer and methods of use thereof. United States Patent US 6696424B1. 2004 Feb 24.
114. Camilleri P, Engberts JBFN, Fieldon ML, Kremer A, inventors; SmithKline- Beecham plc, assignee. Polyhydroxy diamine surfactants and their use in gene transfer. United States Patent US 7005300B1. 2006 Feb 28.